Total Payments
$4,091
2022 Payments
$224.14
Companies
18
Transactions
70
Medicare Patients
4,174
Medicare Billing
$413,068
Payment Breakdown by Category
Food & Beverage$2,091 (51.1%)
Consulting$2,000 (48.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,091 | 68 | 51.1% |
| Consulting Fee | $2,000 | 2 | 48.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $2,000 | 2 | $0 (2019) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $552.25 | 13 | $0 (2021) |
| Aerie Pharmaceuticals, Inc. | $363.36 | 9 | $0 (2021) |
| Shire North American Group Inc | $250.93 | 9 | $0 (2019) |
| Allergan, Inc. | $192.66 | 5 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $122.79 | 6 | $0 (2022) |
| Oyster Point Pharma, Inc. | $122.07 | 1 | $0 (2022) |
| Johnson & Johnson Surgical Vision, Inc. | $118.60 | 1 | $0 (2021) |
| Alcon Vision LLC | $87.44 | 5 | $0 (2022) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $65.54 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $224.14 | 6 | Oyster Point Pharma, Inc. ($122.07) |
| 2021 | $297.20 | 12 | Johnson & Johnson Surgical Vision, Inc. ($118.60) |
| 2020 | $288.83 | 10 | Sun Pharmaceutical Industries Inc. ($159.54) |
| 2019 | $2,651 | 20 | Vertical Pharmaceuticals, LLC ($2,000) |
| 2018 | $444.60 | 16 | Aerie Pharmaceuticals, Inc. ($129.89) |
| 2017 | $184.66 | 6 | Sun Pharmaceutical Industries Inc. ($114.27) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/27/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $122.07 | General |
| Category: DRY EYE | ||||||
| 10/27/2022 | GLAUKOS CORPORATION | ISTENT INJECT W (Device), IACCESS | Food and Beverage | Cash or cash equivalent | $20.22 | General |
| Category: GLAUCOMA | ||||||
| 08/20/2022 | Alcon Vision LLC | rocklatan (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Glaucoma | ||||||
| 06/10/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/01/2022 | EYEVANCE PHARMACEUTICALS LLC | TobraDex ST (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: OPHTHALMIC | ||||||
| 03/11/2022 | BioTissue Holdings, Inc. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 11/12/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), Xelpros | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Ophthalmology | ||||||
| 11/11/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Ophthalmology | ||||||
| 10/20/2021 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Glaucoma | ||||||
| 09/24/2021 | Johnson & Johnson Surgical Vision, Inc. | — | Food and Beverage | In-kind items and services | $118.60 | General |
| 08/04/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/16/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug), LOTEMAX SM | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Ophthalmology | ||||||
| 06/11/2021 | Allergan, Inc. | RESTASIS MULTIDOSE (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: DRY EYE | ||||||
| 05/13/2021 | Alcon Vision LLC | AcrySof IQ VIVITY IOL (Device) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Ophthalmology | ||||||
| 03/31/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: TEPEZZA | ||||||
| 03/19/2021 | Allergan, Inc. | RESTASIS MULTIDOSE (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: DRY EYE | ||||||
| 02/25/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/17/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Ocular | ||||||
| 12/09/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug), ALREX, LOTEMAX SM | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/02/2020 | Sun Pharmaceutical Industries Inc. | XELPROS (Drug), CEQUA, BROMSITE | Food and Beverage | Cash or cash equivalent | $20.57 | General |
| Category: Ophthalmology | ||||||
| 11/18/2020 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: OCULAR | ||||||
| 11/14/2020 | Sun Pharmaceutical Industries Inc. | XELPROS (Drug), BROMSITE, CEQUA | Food and Beverage | Cash or cash equivalent | $23.37 | General |
| Category: Ophthalmology | ||||||
| 10/21/2020 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/21/2020 | Alcon Vision LLC | AcrySof IQ PanOptix (Device) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Ophthalmology | ||||||
| 07/31/2020 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Glaucoma | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 105 | 105 | $40,532 | $6,476 |
| 2022 | 14 | 1,187 | 1,337 | $662,980 | $110,147 |
| 2021 | 12 | 1,549 | 1,744 | $953,511 | $167,382 |
| 2020 | 13 | 1,333 | 1,481 | $448,743 | $129,062 |
Total Patients
4,174
Total Services
4,667
Medicare Billing
$413,068
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 60 | 60 | $29,220 | $4,653 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 22 | $7,832 | $1,235 | 15.8% |
| 92134 | Imaging of retina | Office | 2023 | 12 | 12 | $1,896 | $307.75 | 16.2% |
| 92133 | Imaging of optic nerve | Office | 2023 | 11 | 11 | $1,584 | $280.60 | 17.7% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 31 | 56 | $119,448 | $23,567 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 238 | 272 | $137,632 | $21,319 | 15.5% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2022 | 54 | 76 | $97,888 | $17,887 | 18.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 215 | 215 | $104,705 | $16,449 | 15.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 216 | 256 | $91,136 | $14,292 | 15.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $28,294 | $3,491 | 12.3% |
| 92133 | Imaging of optic nerve | Office | 2022 | 131 | 132 | $19,008 | $3,151 | 16.6% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 69 | 74 | $17,622 | $2,833 | 16.1% |
| 92134 | Imaging of retina | Office | 2022 | 72 | 74 | $11,634 | $2,069 | 17.8% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 25 | 25 | $14,500 | $1,956 | 13.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 33 | 54 | $9,747 | $1,362 | 14.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $8,341 | $1,331 | 16.0% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 18 | 18 | $1,944 | $240.79 | 12.4% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 23 | 23 | $1,081 | $200.21 | 18.5% |
| 66984 | Removal of cataract with insertion of lens, simple | Facility | 2021 | 83 | 138 | $294,354 | $57,236 | 19.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 639 | 680 | $340,612 | $57,129 | 16.8% |
| 66821 | Removal of recurring cataract in lens capsule using laser | Facility | 2021 | 48 | 64 | $82,414 | $15,001 | 18.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 122 | 122 | $80,051 | $11,877 | 14.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 114 | 131 | $46,084 | $7,200 | 15.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 92 | 110 | $23,793 | $4,262 | 17.9% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2021 | 91 | 132 | $25,818 | $4,145 | 16.1% |
About Dr. Mark Bergmann, MD
Dr. Mark Bergmann, MD is a Ophthalmology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669431805.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Bergmann, MD has received a total of $4,091 in payments from pharmaceutical and medical device companies, with $224.14 received in 2022. These payments were reported across 70 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,091).
As a Medicare-enrolled provider, Bergmann has provided services to 4,174 Medicare beneficiaries, totaling 4,667 services with total Medicare billing of $413,068. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Cincinnati, OH
- Active Since 03/17/2006
- Last Updated 12/31/2013
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1669431805
Products in Payments
- XIIDRA (Drug) $332.93
- Rhopressa (Drug) $307.85
- CEQUA (Drug) $208.33
- BROMSITE (Drug) $152.27
- TYRVAYA (Drug) $122.07
- LUMIGAN (Drug) $121.72
- Bromsite (Drug) $114.27
- rocklatan (Drug) $70.46
- ReSTOR (Device) $54.56
- PROLENSA (Drug) $54.28
- INVELTYS (Drug) $51.17
- XELPROS (Drug) $43.94
- RESTASIS (Drug) $37.48
- RESTASIS MULTIDOSE (Drug) $33.46
- Cequa (Drug) $33.44
- PROKERA (Device) $29.16
- AcrySof (Device) $28.83
- SIMBRINZA (Biological) $22.77
- ISTENT INJECT W (Device) $20.22
- AcrySof IQ PanOptix (Device) $19.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Cincinnati
Dr. Robert Osher, Md, MD
Ophthalmology — Payments: $1.2M
Ophthalmology $1.2M
Dr. Christopher Riemann, M.d, M.D
Ophthalmology — Payments: $750,272
Ophthalmology $750,272
Dr. Anup Khatana, Md, MD
Ophthalmology — Payments: $418,163
Ophthalmology $418,163
Dr. Michael Snyder, M.d, M.D
Ophthalmology — Payments: $344,869
Ophthalmology $344,869
Dr. Daniel Miller, Md, MD
Ophthalmology — Payments: $99,161
Ophthalmology $99,161
Dr. Hisham Arar, Md, MD
Ophthalmology — Payments: $79,380
Ophthalmology $79,380